bf/NASDAQ:MRKR_icon.jpeg

COM:MARKERTHERAPEUTICS

Marker Therapeutics

  • Stock

Last Close

3.18

21/11 21:00

Market Cap

44.42M

Beta: -

Volume Today

41.89K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
205.99K
-
213.19K
3.50%
466.79K
118.95%
1.24M
166.01%
9.00M
625.17%
3.31M
63.23%
cost of revenue
gross profit
205.99K
-
213.19K
3.50%
466.79K
118.95%
1.24M
166.01%
9.00M
625.17%
3.31M
63.23%
selling and marketing expenses
general and administrative expenses
2.00M
-
3.18M
58.88%
4.45M
39.78%
4.69M
5.50%
6.41M
36.65%
24.38M
280.22%
9.98M
59.08%
10.47M
4.96%
12.92M
23.42%
12.82M
0.81%
7.48M
41.69%
selling general and administrative expenses
2.00M
-
3.18M
58.88%
4.45M
39.78%
4.69M
5.50%
6.41M
36.65%
24.38M
280.22%
9.98M
59.08%
10.47M
4.96%
12.92M
23.42%
12.82M
0.81%
7.48M
41.69%
research and development expenses
661.63K
-
189K
71.43%
1.71M
805.38%
3.80M
122.07%
5.25M
38.18%
124.00M
2,261.42%
12.76M
89.71%
18.88M
47.91%
27.79M
47.21%
26.14M
5.96%
10.42M
60.15%
other expenses
1.83K
-
-183.06K
10,114.44%
116.05M
63,490.40%
-2.41M
-
-232.97K
90.32%
cost and expenses
2.66M
-
3.37M
26.52%
6.16M
82.71%
8.26M
34.13%
11.48M
38.97%
148.38M
1,192.48%
22.74M
84.67%
29.35M
29.07%
40.72M
38.73%
38.96M
4.32%
17.89M
54.07%
operating expenses
2.66M
-
3.37M
26.52%
6.16M
82.71%
8.26M
34.13%
11.48M
38.97%
148.38M
1,192.48%
22.74M
84.67%
29.35M
29.07%
40.72M
38.73%
38.96M
4.32%
17.89M
54.07%
interest expense
1.76M
-
575.54K
67.23%
10.93K
98.10%
-15.09K
-
ebitda
-2.66M
-
-3.37M
26.52%
-6.16M
82.71%
-8.26M
34.10%
-11.98M
45.02%
-148.13M
1,136.71%
-22.26M
84.97%
-27.84M
25.07%
-36.32M
30.44%
-26.27M
27.67%
-14.58M
44.48%
operating income
-3.31M
-
-3.37M
1.84%
-6.16M
82.71%
-8.49M
37.88%
-11.66M
37.34%
-148.17M
1,170.43%
-22.53M
84.80%
-28.89M
28.22%
-39.48M
36.67%
-29.95M
24.15%
-14.58M
51.31%
depreciation and amortization
-466.28K
-
-26.94M
5,676.92%
-27.90M
3.56%
6.04M
121.64%
680.93K
88.72%
213.72K
68.61%
268.58K
25.67%
1.04M
288.96%
3.16M
202.74%
3.68M
16.37%
2
100.00%
total other income expenses net
-1.11M
-
-26.94M
2,322.70%
-27.90M
3.56%
5.81M
120.81%
497.87K
91.42%
-40K
108.03%
1.10M
2,852.11%
179.74K
83.67%
-2.40M
1,435.73%
15.09K
100.63%
539.16K
3,473.20%
income before tax
-5.53M
-
-30.88M
458.21%
-34.07M
10.31%
-2.46M
92.79%
-10.98M
347.27%
-147.96M
1,247.25%
-21.43M
85.52%
-28.71M
33.97%
-41.88M
45.89%
-29.93M
28.53%
-14.04M
53.08%
income tax expense
466.28K
-
26.94M
5,676.92%
27.90M
3.56%
-6.04M
121.64%
-680.93K
88.72%
-213.72K
68.61%
-1.10M
415.08%
-179.74K
83.67%
-5.70K
96.83%
-15.09K
164.72%
3.67K
124.36%
net income
-5.53M
-
-30.88M
458.21%
-34.07M
10.31%
-2.46M
92.79%
-10.98M
347.27%
-147.96M
1,247.25%
-20.33M
86.26%
-28.53M
40.34%
-41.87M
46.79%
-29.92M
28.56%
-16.97M
43.28%
weighted average shs out
9.47K
-
128.88K
1,261.32%
366.23K
184.17%
688.99K
88.13%
945.35K
37.21%
1.91M
101.96%
4.56M
138.78%
4.70M
3.19%
7.65M
62.64%
8.35M
9.16%
8.81M
5.49%
weighted average shs out dil
9.47K
-
128.88K
1,261.32%
366.23K
184.17%
742.10K
102.63%
945.35K
27.39%
1.91M
101.96%
4.56M
138.78%
4.70M
3.19%
7.65M
62.64%
8.35M
9.16%
8.81M
5.49%
eps
-584.40
-
-239.63
59.00%
-93.02
61.18%
-3.56
96.17%
-11.62
226.40%
-77.50
566.95%
-4.46
94.25%
-6.06
35.87%
-5.47
9.74%
-3.58
34.55%
-1.93
46.09%
epsdiluted
-584.40
-
-239.63
59.00%
-93.02
61.18%
-3.31
96.44%
-11.62
251.06%
-77.50
566.95%
-4.46
94.25%
-6.06
35.87%
-5.47
9.74%
-3.58
34.55%
-1.93
46.09%

All numbers in (except ratios and percentages)